Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Augmedics.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Astrazeneca, Biogen, Neurizon, Recce, Samsung.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alvogene, Biogen, BMS, Eisai, Inflarx, Kane, Merck, Regeneron, Samsung Bioepis, Sandoz, Sanofi.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Brightheart, Philips, Roche, Zimmer Biomet.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Global Institute of Stem Cell Therapy, Kondrion, Leo Pharma, Nurexone, PTC.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Omron, Medtronic.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Genascence, Gensight, Kezar.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Icometrix, Theranica.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abeona, Actuate, Astrazeneca, Attralus, Intercept, J&J, Mirum, Vaxcyte.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Fourth Frontier, GE Medical, Med-El, Smartcardia.